{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:20Z","timestamp":1787775740386,"version":"build-2784847793"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Approximately 25% of individuals with inflammatory bowel disease (IBD) concurrently experience immune-mediated inflammatory diseases (IMIDs), while the overall prevalence of these conditions in the general population is 5\u20137%. Individuals with IBD and concurrent IMIDs tend to have a more aggressive disease profile. We aimed to assess the prevalence of coexisting autoimmune disorders among patients with IBD and their association with inflammatory bowel disease type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this cross-sectional study at a tertiary care center in Riyadh, Saudi Arabia, we examined 875 patients with IBD (530 with Crohn\u2019s disease and 345 with ulcerative colitis). Patient demographics, disease types, treatment modalities, and co-occurring autoimmune conditions were analyzed using statistical and regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Overall, 21.7%, 19.4%, and 25.2% of the patients had IMIDs, Crohn\u2019s disease, and ulcerative colitis, respectively. Patients with ulcerative colitis had higher rates of hepatic autoimmune conditions (9.6%) and endocrine autoimmune diseases (4.1% vs 1.3%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.010) than those with Crohn\u2019s disease (4.5%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). Regression analysis revealed significant associations between hepatic (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.012) and endocrine autoimmune diseases (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.018) with ulcerative colitis diagnosis, although the model\u2019s predictive accuracy was moderate (overall, 63%; specificity, 95%; sensitivity, 14%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study highlights the significant co-occurrence of autoimmune diseases with IBD, particularly the distinct autoimmune profiles of Crohn\u2019s disease and ulcerative colitis. Identifying the specific ulcerative colitis-associated autoimmune comorbidities could guide personalized therapeutic strategies and inform future research on the pathophysiological relationship between these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_259_24","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T08:01:20Z","timestamp":1735545680000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Coexisting autoimmune disorders among patients with inflammatory bowel disease at a tertiary center in Saudi Arabia: A cross-sectional study"],"prefix":"10.4103","author":[{"given":"Ahmed G.","family":"Alghamdi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"},{"name":"Department of Internal Medicine, College of Medicine, Dar Al Uloom University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha M.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas Z.","family":"Nourelden","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam A.","family":"Alhamidi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashaar K.","family":"Al Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishal A.","family":"Alshowair","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"},{"name":"Internal Medicine Department, Hepatobiliary Unit, Alexandria Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Bawazir","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S.","family":"Nagadi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameed M.","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alahmari","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"R1-20250109","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease:Innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R2-20250109","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019:A systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"R3-20250109","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2013.01.042","article-title":"Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines","volume":"31","author":"Tavares Da Silva","year":"2013","journal-title":"Vaccine"},{"key":"R4-20250109","first-page":"2667","article-title":"Inflammatory eye, skin, and bowel disease in spondyloarthritis:genetic, phenotypic, and environmental factors","volume":"28","author":"Brophy","year":"2001","journal-title":"J Rheumatol"},{"key":"R5-20250109","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1185\/030079906X104641","article-title":"Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders:An exploration using US healthcare claims data, 2001-2002","volume":"22","author":"Robinson","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R6-20250109","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016:A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R7-20250109","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/apt.13940","article-title":"The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases","volume":"45","author":"Conway","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-20250109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ecco-jcc\/jjv193","article-title":"Inflammatory bowel disease and the risk of autoimmune diseases","volume":"10","author":"Wilson","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R9-20250109","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.cgh.2019.03.040","article-title":"Incidence of immune-mediated inflammatory diseases among patients with inflammatory bowel diseases in Denmark","volume":"17","author":"Burisch","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-20250109","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement:Guidelines for reporting observational studies*","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"R11-20250109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1:Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R12-20250109","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ecco-jcc\/jjy166","article-title":"The association of inflammatory bowel diseases with autoimmune disorders:A report from the epi-IIRN","volume":"13","author":"Bar Yehuda","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R14-20250109","year":"2022","journal-title":"R Foundation for Statistical Computing"},{"key":"R15-20250109","first-page":"132","article-title":"Multiple autoimmune syndrome","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Buchar)"},{"key":"R16-20250109","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/gm305","article-title":"Emerging patterns of genetic overlap across autoimmune disorders","volume":"4","author":"Richard-Miceli","year":"2012","journal-title":"Genome Med"},{"key":"R17-20250109","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"R18-20250109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrg2489","article-title":"Detecting shared pathogenesis from the shared genetics of immune-related diseases","volume":"10","author":"Zhernakova","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R19-20250109","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R20-20250109","first-page":"195","article-title":"Inflammatory bowel disease:Autoimmune or immune-mediated pathogenesis?","volume":"11","author":"Wen","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"R21-20250109","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-20021","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R22-20250109","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.crohns.2011.10.007","article-title":"Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease:A report of 21 cases","volume":"6","author":"Guerra","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R23-20250109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"R24-20250109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(01)00002-4","article-title":"Epidemiology of inflammatory bowel disease","volume":"31","author":"Loftus","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"R25-20250109","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1572-0241.2007.01215.x","article-title":"Clustering of inflammatory bowel disease with immune mediated diseases among members of a Northern California-managed care organization","volume":"102","author":"Weng","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R26-20250109","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease:A population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"R27-20250109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.14528","article-title":"Association between psoriasis and inflammatory bowel disease:A Danish nationwide cohort study","volume":"175","author":"Egeberg","year":"2016","journal-title":"Br J Dermatol"},{"key":"R28-20250109","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"Ellinghaus","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R29-20250109","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/MIB.0000000000001169","article-title":"Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease","volume":"23","author":"Eppinga","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R30-20250109","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ecco-jcc\/jjv068","article-title":"Psoriasis phenotype in inflammatory bowel disease:A case-control prospective study","volume":"9","author":"Lolli","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R31-20250109","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-A systematic review and meta-analysis","volume":"14","author":"Alinaghi","year":"2020","journal-title":"J Crohns Colitis"},{"key":"R32-20250109","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2016.08.022","article-title":"Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases:A population-based cross-sectional study","volume":"76","author":"Kim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2015.04.173","article-title":"Hidradenitis suppurativa in patients with inflammatory bowel disease:A population-based cohort study in Olmsted County, Minnesota","volume":"14","author":"Yadav","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20250109","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3748\/wjg.v22.i20.4802","article-title":"Hydradenitis suppurativa and inflammatory bowel disease:An unusual, but existing association","volume":"22","author":"Principi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R35-20250109","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of Hidradenitis suppurativa with inflammatory bowel disease:A systematic review and meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R36-20250109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis:Contrasts and comparisons in children and adults-A comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"R37-20250109","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"R38-20250109","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/BF01296509","article-title":"Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis","volume":"37","author":"Rabinovitz","year":"1992","journal-title":"Dig Dis Sci"},{"key":"R39-20250109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.35.1.84","article-title":"Liver disease in ulcerative colitis:An epidemiological and follow up study in the county of Stockholm","volume":"35","author":"Broom\u00e9","year":"1994","journal-title":"Gut"},{"key":"R40-20250109","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R41-20250109","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R42-20250109","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"R43-20250109","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children:Epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"R44-20250109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5694\/j.1326-5377.1962.tb26935.x","article-title":"Autoimmune disease of the thyroid and colon, with a report of a case of chronic ulcerative colitis in association with Hashimoto's disease and penicillin allergy","volume":"49","author":"Brearley","year":"1962","journal-title":"Med J Aust"},{"key":"R45-20250109","doi-asserted-by":"crossref","first-page":"183.e1","DOI":"10.1016\/j.amjmed.2009.06.030","article-title":"Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease","volume":"123","author":"Boelaert","year":"2010","journal-title":"Am J Med"},{"key":"R46-20250109","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/ddq078","article-title":"Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects","volume":"19","author":"Wang","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R47-20250109","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/jcm8030343","article-title":"Increased risk of diabetes in inflammatory bowel disease patients:A nationwide population-based study in Korea","volume":"8","author":"Kang","year":"2019","journal-title":"J Clin Med"},{"key":"R48-20250109","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15403\/jgld-798","article-title":"Epidemiologic association between inflammatory bowel diseases and type 1 diabetes mellitus:A meta-analysis","volume":"29","author":"Lu","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"R49-20250109","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3889\/oamjms.2021.6835","article-title":"The role of ethnicity in inflammatory bowel disease","volume":"9","author":"Siregar","year":"2021","journal-title":"Open Access Maced J Med Sci"},{"key":"R50-20250109","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.crohns.2012.08.002","article-title":"Ethnicity and the risk of development of Crohn's disease of the ileal pouch","volume":"7","author":"Mukewar","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R51-20250109","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ibd.20223","article-title":"TNFSF15 is an ethnic-specific IBD gene","volume":"13","author":"Picornell","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R52-20250109","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/life13081779","article-title":"Inflammatory bowel disease as a paradoxical reaction to anti-TNF-a treatment\u2014A review","volume":"13","author":"Mihai","year":"2023","journal-title":"Life"},{"key":"R53-20250109","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4254\/wjh.v13.i12.1956","article-title":"Liver manifestations and complications in inflammatory bowel disease:A review","volume":"13","author":"Gaspar","year":"2021","journal-title":"World J Hepatol"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_259_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:41:06Z","timestamp":1787773266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_259_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":52,"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_259_24","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"2024-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}